Journal
DIABETOLOGIA
Volume 55, Issue 6, Pages 1745-1754Publisher
SPRINGER
DOI: 10.1007/s00125-012-2521-5
Keywords
Beta cell proliferation; Glucokinase activator; IRS2; Oxidative stress
Categories
Funding
- Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [19390251, 21390282, 21890213, 23791040]
- Japan Medical Association
- Japan Diabetes Foundation
- Novo Nordisk Pharma
- Suzuken Memorial Foundation
- Naito Foundation
- Yamaguchi Endocrine Research Foundation
- Uehara Memorial Foundation
- Yokohama General Promotion Foundation
- Grants-in-Aid for Scientific Research [24390232, 23591315, 21890213, 23791040, 09J03269] Funding Source: KAKEN
Ask authors/readers for more resources
We investigated changes in the expression of genes involved in beta cell function and proliferation in mouse islets stimulated with glucokinase activator (GKA) in order to elucidate the mechanisms by which GKA stimulates beta cell function and proliferation. Islets isolated from mice were used to investigate changes in the expression of genes related to beta cell function and proliferation stimulated by GKA. In addition, knockout ( (-/-)) mice on a high-fat diet or a high-fat diet containing GKA were used to investigate the effects of GKA on beta cell proliferation in vivo. In wild-type mice, and expression was increased by GKA. In (-/-) mice, GKA administration increased the glucose-stimulated secretion of insulin and expression, but not beta cell proliferation. It was particularly noteworthy that oxidative stress inhibited the upregulation of the and genes induced by GKA. Moreover, whereas neither GKA alone nor exendin-4 alone upregulated the expression of and in the islets of / mice, prior administration of exendin-4 to the mice caused GKA to increase the expression of these genes. GKA-stimulated IRS2 production affected beta cell proliferation but not beta cell function. Oxidative stress diminished the effects of GKA on the changes in expression of genes involved in beta cell function and proliferation. A combination of GKA and an incretin-related agent might therefore be effective in therapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available